Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Matthew Allinder
Observed name:
Allinder, Matthew
Institution:
ImmunityBio (United States)
Observed institutions:
University of Louisville,
GlaxoSmithKline (United Kingdom),
Hammersmith Medicines Research,
GlaxoSmithKline (United States),
PAREXEL International (United States),
ImmunityBio (United States),
Covance (United Kingdom)
show all 7
ORCID:
0000-0003-0554-865X
Observed ORCID:
0000-0003-0554-865X
OpenAlex ID:
A5110291328
GLIMMER: A Randomized Phase 2b Dose-Ranging Trial of Linerixibat in Primary Biliary Cholangitis Patients With Pruritus
2022
·
Cynthia Levy
, Stuart Kendrick
, et al.
·
Clinical Gastroenterology and Hepatology
·
109
PDF
Real-world use of rescue inhaler sensors, electronic symptom questionnaires and physical activity monitors in COPD
2019
·
Russell Bowler
, Matthew Allinder
, et al.
·
BMJ Open Respiratory Research
·
22
PDF
Short Physical Performance Battery: What Does Each Sub-Test Measure in Patients with Chronic Obstructive Pulmonary Disease?
2020
·
Divya Mohan
, Victoria S. Benson
, et al.
·
Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation
·
19
PDF
Pharmacokinetics and ADME Characterization of Intravenous and Oral [14C]-Linerixibat in Healthy Male Volunteers
2021
·
Maciej J. Zamek-Gliszczynski
, David Kenworthy
, et al.
·
Drug Metabolism and Disposition
·
15
PDF
Fibrinogen does not relate to cardiovascular or muscle manifestations in COPD: cross-sectional data from the ERICA study
2018
·
Divya Mohan
, Julia R Forman
, et al.
·
Thorax
·
10
PDF
The Responsiveness of Exercise Tests in COPD
2024
·
Theresa C. Harvey-Dunstan
, Molly M. Baldwin
, et al.
·
CHEST Journal
·
9
PDF
Endocarditis With Fistulization and Rupture of Aortic Root Abscess to the Left Atrium
2015
·
Melissa A. Platt
, Shirali Shah
, et al.
·
Journal of Emergency Medicine
·
3
Improving symptomology in COPD: which therapy would you choose, a brochodilator or pulmonary rehabilitation?
2019
·
Sarah Edwards
, Theresa Harvey-Dunstan
, et al.
·
European Respiratory Journal
·
1
Prevalence of physical limitation in COPD: the short physical performance battery (SPPB)
2018
·
Victoria Benson
, Divya Mohan
, et al.
·
European Respiratory Journal
·
1
Efficacy outcomes in first-line (1L) non–small cell lung cancer (NSCLC) with maintenance of immune competence: QUILT-2.023 randomized phase 3 study of IL-15R agonist nogapendekin alfa inbakicept (NAI) with checkpoint inhibitor (CPI) ± chemotherapy.
2026
·
John M. Wrangle
, Luke P. Dreisbach
, et al.
·
Journal of Clinical Oncology
GLIMMER: A Randomized Phase 2b Dose-Ranging Trial of Linerixibat in Primary Biliary Cholangitis Patients With Pruritus
2023
·
Cynthia Levy
, Stuart Kendrick
, et al.
·
Newcastle University ePrints (Newcastle Univesity)
The Utility of Shapelets for Analyzing Physical Activity of COPD Patients and non-COPD controls
2019
·
Yuan An
, Siling Chen
, et al.
·
IEEE International Conference on Bioinformatics and Biomedicine (BIBM)
Missing a signal in exercise outcomes–is ventilatory limitation a factor in COPD?
2019
·
Theresa Harvey-Dunstan
, Ruth Tal-Singer
, et al.
·
European Respiratory Journal
Real-world use of rescue inhaler sensors, electronic symptom questionnaires and physical activity monitors in COPD
2019
·
Russell Bowler
, Matthew Allinder
, et al.
Late Breaking Abstract - Co-morbid disease clusters in chronic obstructive pulmonary disease: the ERICA study
2017
·
Divya Mohan
, Matthew Allinder
, et al.
·
European Respiratory Journal
Show more works
View as search
Works count:
16
Citation count:
189
H-index:
6
I10-index:
5
Year
Topic
Type
